FDA Policy for REMS Reqmts during COVID-19
Health Care, Pharma Industry, Strategic Planning
FDA is issuing this guidance to communicate its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements for the duration of the coronavirus pandemic public health emergency.
Read the Policy now
Related Education Resources.
All ResourcesGuy Disney - European Knowledge Forum Keynote Speaker 2022
Topic: Conference
Video
Members
2020 Virtual Conference: Presentation and Workshop Slides
Topics: Communication, Conference, Personal Development, Pharma Industry
Presentation
Members
Recent Developments in the Global Regulatory Landscape
Topic: Regulatory
Webinar
Free
